Zeina Dardari

TL;DR: Negative results of atherosclerosis-imaging tests, particularly coronary artery calcium score of 0, resulted in the greatest downward shift in estimated CVD risk, which may help guide discussions on the identification of individuals less likely to receive net benefit from lifelong preventive pharmacotherapy.

TL;DR: The overall findings support that measures beyond the Agatston score provide important clues to sex differences in atherosclerotic plaque and may further refine risk detection and focus preventive strategies of care.

TL;DR: In this article, the authors sought to determine if coronary artery calcium (CAC) is associated with incident noncardiovascular disease and found that those with CAC ≥ 400 had an increased hazard of cancer (hazard ratio [HR]: 1.53; 95% confidence interval [CI]: 1 18 to 1.99), chronic kidney disease (CKD), deep vein thrombosis/pulmonary embolism, hip fracture and dementia.

TL;DR: In an ethnically diverse population without known CVD at baseline, there was a strong, independent association between higher resistin levels and incident CVD, CHD and HF.

TL;DR: The number of coronary arteries with calcified plaque, indicating increasingly "diffuse" multivessel subclinical atherosclerosis, adds significantly to the traditional Agatston CAC score for the prediction of CHD and CVD events.